February 2019 Briefing - Dermatology

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Tumor Control Durable With Pembrolizumab in Merkel Cell Cancer

WEDNESDAY, Feb. 27, 2019 (HealthDay News) -- For patients with advanced Merkel cell carcinoma (aMCC), pembrolizumab is associated with durable tumor control and favorable overall survival, according to a study published online Feb. 7 in the Journal of Clinical Oncology.

Abstract/Full Text (subscription or payment may be required)

2014 to 2017 Saw Improvement in Burnout for U.S. Physicians

MONDAY, Feb. 25, 2019 (HealthDay News) -- From 2014 to 2017, there was an improvement in burnout and satisfaction with work-life integration among U.S. physicians, according to a study published online Feb. 22 in the Mayo Clinic Proceedings.

Abstract/Full Text

National Health Spending Set to Increase 5.5 Percent Annually

FRIDAY, Feb. 22, 2019 (HealthDay News) -- National health spending is projected to increase at an annual rate of 5.5. percent from 2018 to 2027, with fundamental economic and demographic factors the main drivers, according to a report published online Feb. 20 in Health Affairs.

Abstract/Full Text (subscription or payment may be required)

Most Patients Do Not Disclose Complementary Medicine Use

FRIDAY, Feb. 22, 2019 (HealthDay News) -- Just one-third of users of biologically based complementary medicine (CM) disclose their use to traditional health care providers, according to a review published online Feb. 7 in Scientific Reports.

Abstract/Full Text

Guideline Covers Extracutaneous Manifestations of Psoriasis

FRIDAY, Feb. 22, 2019 (HealthDay News) -- The extracutaneous manifestations of psoriasis and guidance on use of biologic treatment for management of psoriasis are discussed in two new guidelines published online Feb. 13 in the Journal of the American Academy of Dermatology.

Abstract/Full Text - Elmets
Abstract/Full Text - Menter

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

THURSDAY, Feb. 21, 2019 (HealthDay News) -- The U.S. Food and Drug Administration took steps Thursday to tighten regulation of over-the-counter sunscreen products.

More Information: FDA
More Information: EWG

Vertical Integration Has Little Impact on Quality Measures

THURSDAY, Feb. 21, 2019 (HealthDay News) -- Vertical integration between hospitals and physicians has little impact on quality measures, while increased hospital market concentration is strongly associated with reduced quality in measures of patient satisfaction, according to a study published online Feb. 9 in Medical Care Research and Review.

Abstract/Full Text

New Kaiser Permanente Medical School Plans to Waive Tuition

WEDNESDAY, Feb. 20, 2019 (HealthDay News) -- A new medical school to be opened by California-based health system Kaiser Permanente will waive tuition for all students in its first five graduating classes.

The New York Times Article
More Information

Hospital Prices Growing Faster Than Physician Prices

FRIDAY, Feb. 15, 2019 (HealthDay News) -- Growth in hospital prices and payments outpaced growth in physician prices and payments from 2007 through 2014, according to a report published in the February issue of Health Affairs.

Abstract/Full Text (subscription or payment may be required)

Health Care Spending Per Person Increased to $5,641 in 2017

TUESDAY, Feb. 12, 2019 (HealthDay News) -- In 2017, health care spending per person reached $5,641, according to the Health Care Cost Institute (HCCI) annual Health Care Cost and Utilization Report.

Health Care Cost and Utilization Report

Many Systematic Reviews Do Not Fully Report Adverse Events

TUESDAY, Feb. 12, 2019 (HealthDay News) -- Many systematic review protocols in the International Prospective Register of Systematic Reviews (PROSPERO) do not include adverse event reporting, according to a study published in the April issue of the Journal of Clinical Epidemiology.

Abstract/Full Text

Acne Relapses Linked to Lower Quality of Life, Productivity

TUESDAY, Feb. 12, 2019 (HealthDay News) -- Acne relapses are significantly associated with impaired quality of life as well as productivity loss and absenteeism, according to a study recently published in the Journal of the European Academy of Dermatology and Venereology.

Abstract/Full Text (subscription or payment may be required)

Johnson & Johnson to Provide Drug Prices in TV Ads

FRIDAY, Feb. 8, 2019 (HealthDay News) -- In a drug industry first, Johnson & Johnson will start giving the list prices of its prescription drugs in television ads.

AP News Article

Measles Outbreak Triggers Sharp Rise in Demand for Vaccine

FRIDAY, Feb. 8, 2019 (HealthDay News) -- Health clinics in Clark County, Washington, are scrambling to meet the sharply increased demand for measles vaccination as people seek protection during an outbreak of the highly contagious virus.

Kaiser Health News Article

Psoriasis Tx Linked to Drop in Noncalcified Coronary Plaque

WEDNESDAY, Feb. 6, 2019 (HealthDay News) -- Treatment of psoriasis with biologic therapy is associated with a reduction in noncalcified coronary plaque and improved plaque morphology, according to a study published online Feb. 5 in Cardiovascular Research.

Abstract/Full Text

Washington State Measles Cases Now at 48 Since Jan. 1

MONDAY, Feb. 4, 2019 (HealthDay News) -- There have been 48 confirmed cases of measles in Washington state since the start of the year as health officials struggle to stop the spread of the infectious disease.

CNN Article

Related Stories

No stories found.
logo
www.healthday.com